Item 7.01 Regulation FD Disclosure

On January 11, 2022, Revelation Biosciences, Inc. ("Revelation") posted an investor presentation on its website, www.revbiosciences.com.

The information in this Item 7.01 (including Exhibit 99.1) is being furnished and shall not be deemed to be filed for purposes of Section 18 of the Exchange Act, or otherwise be subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.

Item 9.01. Financial Statements and Exhibits





(c) Exhibits:



Exhibit No.   Description
99.1            Investor Presentation January 2022
104           Cover Page Interactive Data File (embedded within the Inline XBRL document)




                                       1

© Edgar Online, source Glimpses